Celldex (CLDX) Announces Proposed Common Share Offering

Go back to Celldex (CLDX) Announces Proposed Common Share Offering

Celldex (CLDX) Prices 13.378M Share Common Offering at $9.75/Sh

June 16, 2020 5:51 AM UTC

Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced the pricing of its previously announced underwritten public offering. Celldex is offering 13,377,926 shares of its common stock, par value $0.001 per share, at a price to the public of $9.75 per share. In connection with the offering, Celldex... More

Celldex Therapeutics (CLDX) PT Raised to $12 at Cantor Fitzgerald After Positive CDX-0159 Data

June 12, 2020 6:33 AM UTC

Cantor Fitzgerald analyst Kristen Kluska raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $12.00 (from $8.00) after including the CDX-0159 data that were presented on 6/6 and shifting to a DCF based model. Shares rose 193% over the last two days, in part, due to insider buying... More